W Endoluminal Robotics

Company Overview

Snapshot

Founded in October 2020 by Prof. Nir Shvalb, W Endoluminal Robotics operates with 1–10 employees. The company has raised $260,000 across two funding rounds from one investor. In May 2023, the company secured funding from Peregrine Ventures.

Business overview

W Endoluminal Robotics is a Health Tech & Life Sciences company focused on developing solutions for the early diagnosis and treatment of lung cancer. The company's core technology involves novel mechanical solutions and advanced control algorithms, enabling limitless accessibility within the lungs for true live confirmation. This technology aims to revolutionize diagnostics by increasing certainty in lung biopsies and facilitating advanced lung treatment solutions, thereby reducing the burden on hospitals. W Endoluminal Robotics operates in the medical devices, diagnostics devices, and robotics sectors, serving the healthcare and life sciences industries, specifically targeting providers.

Company Intelligence Q&A

What is W Endoluminal Robotics' primary focus?

W Endoluminal Robotics is focused on developing solutions for the early diagnosis and treatment of lung cancer, utilizing advanced robotic technology for improved accessibility and certainty in lung biopsies.

When was W Endoluminal Robotics founded?

W Endoluminal Robotics was founded in October 2020.

Who is a founder of W Endoluminal Robotics?

Prof. Nir Shvalb is a founder of W Endoluminal Robotics.

What is the company's employee count?

W Endoluminal Robotics operates with 1–10 employees.

What is the total capital raised by W Endoluminal Robotics?

W Endoluminal Robotics has raised a total of $260,000 across two funding rounds.